GammaDelta Therapeutics

0 followers


GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.

Employees

51-200

Links

This is an unverified company page

Org chart

Collapse
Sandra Van Wetering
VP Process Science and Manufacturing
Emma Roffe
Director

Teams

This company has no teams yet


Offices